haloperidol has been researched along with Cirrhosis, Liver in 6 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Acquired hepatocerebral degeneration (AHD) and hepatolenticular degeneration can have similar clinical presentations, but when a chronic liver disease and atypical motor findings coexist, the distinction between AHD and hepatic encephalopathy (HE) can be even more complicated." | 1.37 | Acquired hepatocerebral degeneration and hepatic encephalopathy: correlations and variety of clinical presentations in overt and subclinical liver disease. ( Américo, MF; Caramori, CA; Romeiro, FG; Santos, AC; Schelp, AO; Silva, GF; Yamashiro, FS, 2011) |
| "Rats with liver cirrhosis were more tolerant than normal rats 6 h after bile duct ischemia (P < 0." | 1.37 | Cholangiocytes of cirrhotic rats are more tolerant to ischemia than normal rats: a role for abnormal hepatic arteriovenous communications? ( Jiang, J; Li, DZ; Miao, Y, 2011) |
| "A fatal case of Neuroleptic Malignant Syndrome (NMS) affecting a middle-aged woman is presented." | 1.29 | A fatal case of neuroleptic malignant syndrome. ( Lannas, PA; Pachar, JV, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Romeiro, FG | 1 |
| Américo, MF | 1 |
| Yamashiro, FS | 1 |
| Caramori, CA | 1 |
| Schelp, AO | 1 |
| Santos, AC | 1 |
| Silva, GF | 1 |
| Lannas, PA | 1 |
| Pachar, JV | 1 |
| Migneco, G | 1 |
| Mascarella, A | 1 |
| Tripi, S | 1 |
| La Cascia, C | 1 |
| Navetta, A | 1 |
| O'Neill, DP | 1 |
| Klawans, HL | 1 |
| Holmes, AW | 1 |
| Melikian, V | 1 |
| Eddy, JD | 1 |
| Paton, A | 1 |
| Li, DZ | 1 |
| Jiang, J | 1 |
| Miao, Y | 1 |
6 other studies available for haloperidol and Cirrhosis, Liver
| Article | Year |
|---|---|
Acquired hepatocerebral degeneration and hepatic encephalopathy: correlations and variety of clinical presentations in overt and subclinical liver disease.
Topics: Anti-Dyskinesia Agents; Diagnosis, Differential; Disease Progression; Female; Haloperidol; Hepatic E | 2011 |
A fatal case of neuroleptic malignant syndrome.
Topics: Adult; Chemical and Drug Induced Liver Injury, Chronic; Female; Haloperidol; Humans; Liver Cirrhosis | 1993 |
[Cytolytic episodes during cirrhosis].
Topics: Antipyrine; Anxiety Disorders; Barbiturates; Caffeine; Cholestasis; Drug Therapy, Combination; Femal | 1986 |
Treatment of choreoathetotic movements in chronic liver disease with a dopamine-blocking agent. Pathophysiologic implications.
Topics: Aged; Basal Ganglia; Brain Diseases; Chorea; Dopamine; Electrocardiography; Electroencephalography; | 1971 |
The stimulant effect of drugs on indocyanine green clearance by the liver.
Topics: Adult; Aged; Anticonvulsants; Densitometry; Drug Therapy; Ear, External; Female; Half-Life; Haloperi | 1972 |
Cholangiocytes of cirrhotic rats are more tolerant to ischemia than normal rats: a role for abnormal hepatic arteriovenous communications?
Topics: Animals; Apoptosis; Arteriovenous Fistula; Bile Ducts; Blood Circulation; Disease Models, Animal; Ep | 2011 |